Researchers plan to test intravenous drug candidate for Alzheimer's

05/4/2010 | KENS-TV (San Antonio)

Researchers at the University of Texas Health Science Center at San Antonio are preparing to conduct a trial of an experimental drug for Alzheimer's disease. The drug, solanezumab, is administered intravenously monthly and is intended to target amyloid plaques in the brain. To measure the drug's effectiveness, study participants will undergo PET scans.

View Full Article in:

KENS-TV (San Antonio)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA